SEC Filings
BlackRock Now Holds 5.1% Of BridgeBio Pharma, With 9.9 Million Shares
The asset manager's passive ownership disclosure lists 9,892,226 shares and says it is not seeking to influence control.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
SEC Filings
The asset manager's passive ownership disclosure lists 9,892,226 shares and says it is not seeking to influence control.
SEC Filings
The asset manager's passive filing puts sole voting power over about 281.5 million shares, with ExxonMobil due to report Friday.
SEC Filings
The asset manager's passive filing lists 11,937,882 Editas shares and says none were bought to influence control of the gene-editing company.
SEC Filings
The asset manager's passive ownership filing puts its stake at 527,115 Class A shares as of September 30, 2026.
SEC Filings
The asset manager's passive filing shows sole voting power over 330,149 shares of the cancer and Wilson disease drug developer.
SEC Filings
The asset manager reports 5.01% of the gene-editing company's common stock in a passive ownership filing.
SEC Filings
BlackRock reported 5,339,458 shares of the Crohn's-focused biotech, with sole voting power over 5,221,737 of them.
SEC Filings
The asset manager's passive ownership filing counts the shares as of September 30, with sole voting power over 3,226,537 of them.
SEC Filings
The asset manager certified the holding is for ordinary business, not to influence control of the truck-dealership operator.
Earnings
The company's first-ever guidance raise came alongside a $91.9 million quarterly net loss, mostly from a non-cash goodwill charge.
Earnings
Kevin McAleenan pitched the AI software maker as an applications player as investors scrutinize the cost of the infrastructure build.
Deals
About 39.2 million shares voted for the deal at a virtual special meeting, and the company expects to close on or about November 2.